dengu
fever
df
one
world
emerg
infecti
diseas
steadi
increas
european
tourist
well
soldier
serv
peacekeep
duti
endem
area
coupl
present
resurg
dengu
rais
risk
exposur
larg
number
european
travel
signific
number
travel
fact
develop
df
risk
dengu
haemorrhag
fever
dhf
travel
revisit
place
potenti
acquir
also
spread
dengu
viral
infect
concern
potenti
dengu
outbreak
previous
denguefre
countri
import
case
anoth
major
concern
potenti
area
dengu
transmiss
due
spread
vector
sizeabl
part
southern
europ
addit
risk
haemorrhag
fever
return
tourist
introduct
df
return
travel
whether
symptom
unaffect
sign
symptom
diseas
pose
threat
health
system
europ
occur
annual
togeth
estim
hospit
case
dengu
haemorrhag
fever
dengu
shock
syndrom
dhfdss
offici
note
mortal
rate
per
year
df
endem
countri
southern
southeast
asia
western
pacif
region
central
south
america
caribbean
africa
fig
incid
epidem
endem
dengu
increas
substanti
notabl
america
sinc
variou
epidem
occur
latin
america
dhf
rare
diseas
saw
dramat
geograph
expans
epidem
df
dhf
southeast
asia
south
pacif
island
caribbean
latin
america
region
chang
nonendem
hypoendem
hyperendem
mani
endem
area
popular
tourist
destin
steadili
increas
number
tourist
visit
endem
area
coupl
present
resurg
dengu
rais
risk
exposur
larg
number
travel
df
also
emerg
problem
troop
deploy
dengueendem
tropic
countri
diseas
princip
transmit
mosquito
aed
aegypti
aed
albopictu
vector
shown
remark
complianc
environment
chang
human
habitat
aegypti
princip
vector
found
worldwid
tropic
subtrop
fig
vector
mosquito
daytim
feeder
well
adapt
urban
environ
breed
tire
can
water
jar
near
human
dwell
femal
transmit
diseas
readili
predilect
human
blood
habit
multipl
interrupt
feed
mani
area
df
endem
polici
mosquito
control
nonexist
far
success
among
factor
implic
current
extent
dengu
unplan
uncontrol
urban
overpopul
crowd
poverti
weaken
public
health
infrastructur
intern
journey
introduc
new
serotyp
genotyp
new
strain
differ
part
world
df
caus
singlestrand
nonseg
ribonucl
acid
rna
viru
famili
flavivirida
genu
flaviviru
human
main
reservoir
dengu
viru
although
nonhuman
primat
asia
africa
may
also
infect
four
distinct
serotyp
recogn
infect
virus
may
asymptomat
may
caus
selflimit
febril
ill
known
df
small
percentag
case
may
result
lifethreaten
syndrom
socal
dhfdss
infect
one
serotyp
provid
lifelong
homolog
immun
transient
crossprotect
serotyp
thu
allow
sequenti
infect
possibl
progress
dhfdss
pathogenesi
dhfdss
partial
understood
today
major
view
antibodi
depend
viral
infect
enhanc
main
mechan
respons
induc
dhfdss
associ
secondari
dengu
viru
infect
endem
area
patient
df
either
asymptomat
present
mild
febril
ill
ill
rang
asymptomat
infect
undifferenti
fever
benign
df
sever
haemorrhag
fever
without
shock
syndrom
incub
period
day
infect
mosquito
bite
diseas
usual
begin
sudden
onset
fever
headach
typic
accompani
follow
chilli
retroorbit
pain
photophobia
backach
sever
muscl
ach
arthralgia
high
fever
may
sustain
day
also
flush
faci
lymph
node
enlarg
posit
tourniquet
test
petichea
epistaxi
gastrointestin
bleed
may
observ
rash
typic
macular
maculopapular
often
confluent
spare
small
island
normal
skin
report
half
infect
person
last
day
fig
rare
complic
df
includ
myocard
hepat
encephalopathi
neuropathi
usual
convalesc
occur
abruptli
sometim
may
prolong
sever
week
associ
asthenia
classic
df
travel
although
selflimit
rare
fatal
incapacit
may
prevent
one
travel
may
requir
hospit
four
major
clinic
manifestationshigh
fever
haemorrhag
phenomena
often
hepatomegali
circulatori
failur
character
typic
case
dhf
characterist
haemorrhag
manifest
dhf
due
capillari
leakag
patient
dhf
usual
present
manner
similar
df
plasma
leakag
develop
day
onset
diseas
abdomin
pain
vomit
restless
chang
level
conscious
may
first
warn
sign
dhf
dss
character
rapid
weak
puls
profound
hypotens
mortal
rate
dss
may
high
risk
dhf
higher
immigr
person
visit
friend
rel
area
diseas
endem
gener
travel
dss
travel
uncommon
method
use
diagnosi
dengu
infect
includ
viru
isol
serolog
molecular
techniqu
revers
transcriptasepolymeras
chain
reaction
rtpcr
extens
review
dengu
virus
isol
serum
plasma
leukocyt
febril
phase
postmortem
specimen
liver
lung
spleen
lymph
node
thymu
cerebrospin
fluid
pleuralascit
fluid
blood
collect
febril
period
day
ill
neutralis
antibodi
appear
time
form
immun
complex
present
larg
number
case
secondari
df
may
caus
interfer
viru
isol
techniqu
mosquito
cell
line
replac
newborn
mice
cell
cultur
vero
cell
line
babi
hamster
kidney
cell
line
tradit
dengu
viru
isol
carri
current
inocul
mosquito
cell
line
obtain
albopictu
method
choic
viru
isol
done
research
purpos
may
take
long
week
provid
result
clinic
set
viru
isol
reliabl
tool
acut
dengu
viru
infect
particularli
antibodi
respons
initi
serolog
show
denguespecif
igm
igg
reaction
henc
attempt
viru
isol
seem
promis
patient
acut
febril
denguespecif
igm
igg
elisa
wide
use
test
serolog
diagnosi
dengu
infect
patient
measur
igm
antibodi
day
infect
averag
becom
undetect
day
onset
ill
sensit
igm
elisa
rang
specif
serotyp
infect
viru
also
identifi
use
convent
captur
elisa
thu
earli
acut
phase
differenti
diagnosi
desir
igmneg
result
inconclus
therefor
good
enough
clinic
purpos
rtpcr
use
detect
dengu
infect
earli
diseas
antibodi
detect
sensit
specif
rapid
detect
minut
quantiti
dengu
viral
materi
patient
serum
make
rtpcr
sensit
viru
isol
allow
rapid
detect
dengu
infect
result
usual
avail
h
easier
identif
circul
serotyp
pcrbase
diagnosi
use
sinc
posit
earli
cours
diseas
becom
neg
toward
end
febril
period
igm
becom
posit
thu
two
method
complementari
rtpcr
also
use
epidemiolog
studi
dengu
serotyp
identifi
without
crossreact
flavivirus
howev
molecular
techniqu
disadvantag
high
cost
need
expertis
crossreact
flavivirus
interfer
serolog
test
affect
interpret
test
result
travel
expos
flaviviru
infect
includ
previous
vaccin
yellow
fever
japanes
enceph
commonli
use
test
diagnosi
df
igm
captur
elisa
perform
day
onset
symptom
primari
dengu
infect
character
increas
denguespecif
igm
antibodi
earli
stage
diseas
increas
igg
antibodi
day
diseas
secondari
dengu
infect
igm
antibodi
either
absent
lower
primari
infect
high
level
dengu
igg
antibodi
earli
cours
diseas
howev
differenti
may
fals
result
among
person
vaccin
previous
expos
flaviviru
infect
sinc
laboratorybas
diagnosi
dengu
often
unavail
unreli
time
care
clinic
diagnosi
consid
togeth
nonspecif
laboratori
test
establish
diagnosi
df
nonspecif
laboratori
test
find
includ
mark
leucopenia
thrombocytopenia
increas
haematocrit
elev
liver
enzym
malaria
typhoid
fever
leptospirosi
west
nile
viru
infect
chikungunya
measl
rubella
epsteinbarr
viru
infect
viral
haemorrhag
fever
rickettsi
diseas
earli
sever
acut
respiratori
syndrom
sar
consid
differenti
diagnosi
diagnosi
remain
one
base
high
index
suspicion
appropri
clinic
set
pyrexia
unknown
origin
diagnosi
consid
patient
fever
caus
identifi
routin
investig
diagnosi
pyrexia
unknown
origin
often
consid
possibl
selflimit
ill
exclud
routin
protocol
manag
pyrexia
unknown
origin
ask
patient
foreign
travel
howev
manag
acut
fever
short
durat
part
current
teach
encourag
clinician
ask
patient
foreign
travel
given
likelihood
dengu
present
acut
febril
ill
patient
acut
fever
short
durat
also
ask
recent
foreign
travel
although
symptom
sign
mild
febril
ill
df
nonspecif
hard
differenti
mani
undifferenti
febril
syndrom
clinician
tend
treat
patient
suspect
dhf
result
test
avail
milder
infect
nonendem
area
case
european
travel
diagnosi
may
made
caus
febril
ill
would
label
nonspecif
viral
fever
therefor
escap
notif
record
public
health
databas
turn
would
lead
underestim
preval
import
dengu
viral
infect
european
popul
classic
df
treat
antipyret
agent
fluid
replac
bed
rest
sinc
specif
therapeut
agent
avail
treatment
dengu
prompt
adequ
fluid
replac
thought
reduc
mortal
rate
dss
dhf
fluid
replac
administ
oral
parenter
accord
sever
ill
aspirin
nonsteroid
antiinflammatori
drug
best
avoid
due
increas
risk
bleed
platelet
count
haematocrit
repeat
least
everi
h
order
recogn
develop
dhf
decreas
platelet
count
per
mm
rise
haematocrit
n
indic
develop
dhf
dss
afflict
patient
need
intens
care
manag
appropri
fluid
replac
normal
salin
ringer
lactat
patient
worsen
shock
colloid
crystalloid
ad
mlkg
bodi
weight
per
hour
critic
period
often
day
onset
ill
thereaft
capillari
leakag
stop
care
must
taken
avoid
fluid
overload
pulmonari
oedema
consid
risk
exposur
travel
risk
highest
rural
urban
area
inhabit
lower
incom
group
lack
effect
mosquito
control
sinc
prefer
feed
time
mosquito
earli
morn
late
afternoon
prevent
mosquito
bite
rather
difficult
howev
protect
measur
use
mosquito
repel
wear
cloth
keep
skin
exposur
minimum
highli
recommend
risk
acquir
infect
may
lower
mani
prefer
travel
destin
beach
hotel
wellkept
ground
jungl
area
soldier
expect
travel
anywher
time
insect
repel
environment
vector
control
current
line
defenc
mosquito
effect
safe
afford
vaccin
dengu
viru
immedi
prospect
sinc
preexist
heterotyp
antibodi
within
host
increas
risk
dhf
dss
effect
vaccin
offer
protect
four
serotyp
vaccin
attenu
vaccin
virus
evalu
past
thailand
tetraval
formul
virus
current
test
repeat
trial
also
construct
recombin
vaccin
also
evalu
dengu
seldom
recogn
import
diseas
europ
df
diagnos
increas
proport
febril
travel
return
tropic
rang
earli
recent
due
nonspecif
selflimit
natur
milder
infect
figur
like
underestim
caus
underreport
epidemiolog
clinic
manifest
df
endem
countri
extens
describ
report
exist
serolog
manifest
among
travel
popul
europ
exact
extent
travelacquir
import
dengu
infect
among
travel
unknown
grow
import
consider
lack
data
regard
actual
frequenc
infect
intern
travel
variou
case
report
publish
describ
dengu
infect
intern
travel
visit
area
infect
endem
small
number
systemat
studi
topic
serolog
evid
recent
dengu
infect
found
patient
fever
return
area
endem
quot
jelinek
retrospect
studi
perform
among
small
cohort
swiss
travel
show
surprisingli
high
preval
antibodi
dengu
viru
symptomat
patient
similar
result
preval
shown
prospect
studi
febril
returne
endem
area
latter
studi
patient
test
dengu
acquir
infect
southeast
asia
western
indonesia
patient
acquir
brazil
anoth
retrospect
studi
among
german
expatri
worker
famili
stay
area
endem
antibodi
dengu
viru
detect
major
person
test
posit
clinic
diseas
suggest
dengu
appear
mani
infect
may
oligosymptomat
asymptomat
cours
similar
studi
german
aid
worker
seroposit
detect
igg
antibodi
dengu
detect
aid
worker
return
thailand
qualiti
studi
suffer
retrospect
design
consider
lack
data
live
standard
hous
condit
travel
habit
patient
howev
result
show
clearli
dengu
infect
realist
event
longterm
travel
endem
area
appear
also
true
person
repeat
short
journey
laboratoryconfirm
dengu
viru
infect
among
german
travel
return
berlin
studi
retrospect
major
patient
contract
diseas
south
central
southeast
asia
second
largest
group
south
central
america
caribbean
report
dengu
travel
africa
oceania
less
common
retrospect
studi
carri
among
swedish
tourist
df
found
commonli
diagnos
import
arboviru
diseas
patient
diagnos
df
acquir
infect
thailand
spring
earli
summer
patient
recov
without
sequela
anoth
retrospect
studi
among
diagnos
case
df
french
travel
southeast
asia
french
west
indi
french
guyana
africa
show
compar
southeast
asia
french
west
indi
french
guyana
fewer
patient
acquir
infect
africa
prospect
studi
among
spanish
tourist
travel
tropic
diagnos
df
mean
age
year
contract
diseas
asia
central
america
caribbean
island
contract
africa
patient
df
report
network
tropneteurop
european
network
import
infecti
diseas
surveil
period
januari
decemb
confirm
case
accord
definit
use
surveil
network
classifi
probabl
case
suspect
case
major
male
work
age
averag
age
year
overwhelm
major
patient
european
live
europ
european
travel
tourist
geograph
region
infect
df
indonesia
south
southeast
asia
far
largest
contributor
patient
follow
america
patient
visit
southeast
asia
visit
indian
subcontin
visit
indonesia
proport
patient
acquir
infect
america
slightli
smaller
patient
proport
patient
case
acquir
southeast
asia
increas
similar
tendenc
acquir
infect
observ
india
increas
df
also
recogn
emerg
health
problem
troop
deploy
tropic
countri
mainli
lack
effect
prevent
measur
high
attack
rate
high
symptomaticunappar
infect
ratio
long
period
one
unfit
duti
acut
phase
diseas
studi
carri
italian
troop
deploy
east
timor
armi
soldier
contract
probabl
df
probabl
df
case
detect
lowexposur
group
navi
air
forc
personnel
approxim
troop
support
serolog
evid
recent
dengu
infect
show
clinic
manifest
classic
df
milder
symptom
asymptomat
us
troop
deploy
somalia
show
featur
classic
df
patient
perform
duti
outsid
camp
associ
high
risk
infect
probabl
vector
control
activ
regularli
carri
within
compound
measur
taken
personnel
protect
use
bed
net
howev
soldier
duti
night
thu
slept
day
bite
activ
dengu
vector
highest
moreov
previous
infect
soldier
redeploy
endem
area
may
increas
risk
dhfdss
complic
therefor
suggest
risk
taken
account
plan
intern
peacekeep
oper
risk
dhf
among
previous
dengueinfect
militari
personnel
evalu
beforehand
littl
known
clinic
spectrum
df
proport
subclin
infect
among
travel
studi
area
endem
suggest
dengu
infect
caus
atyp
symptom
proport
subclin
infect
among
travel
import
suggest
infect
one
serotyp
dengu
viru
predispos
develop
dhf
andor
dss
reinfect
occur
anoth
serotyp
patient
report
network
tropneteurop
patient
dengu
symptomat
report
fever
headach
myalgia
fatigu
rash
well
diarrhoea
therefor
diagnosi
dengu
viru
infect
consid
patient
present
broad
varieti
symptom
resid
recent
travel
dengueendem
region
dengu
short
incub
period
thu
studi
symptom
tend
begin
return
journey
median
day
return
cours
ill
benign
patient
studi
carri
german
travel
confirm
df
also
show
import
clinic
characterist
fever
prostrat
headach
predominantli
frontal
retroorbit
arthralgia
measleslik
rash
myalgia
also
shown
meaning
laboratori
result
mark
leucopenia
thrombocytopenia
hyponatremia
increas
hepat
enzym
fourteen
percent
haemorrhag
phenomena
median
durat
fever
day
rang
day
major
patient
spanish
studi
postdengu
syndrom
character
mark
asthenia
short
incub
period
diseas
conceiv
mani
infect
travel
may
experi
df
still
abroad
lead
underestim
true
incid
travel
popul
dengu
viru
infect
consid
clinic
sign
travel
histori
possibl
incub
period
day
rang
day
suggest
therefor
import
suspect
df
everi
febril
patient
return
tropic
particularli
thrombocytopenia
elev
serum
aminotransferas
andor
rash
also
present
diagnosi
dengu
consid
second
malaria
travel
return
fever
whenev
suspect
quick
reliabl
laboratori
diagnosi
mandatori
avoid
complic
also
import
keep
mind
igm
igg
dengu
antibodi
may
crossreact
flavivirus
japanes
b
enceph
west
nile
enceph
yellow
fever
rate
igg
crossreact
dengu
infect
japanes
enceph
yellow
fever
vaccin
may
igm
crossreact
found
vaccin
without
doubt
underreport
dengu
case
import
europ
either
patient
seek
medic
care
physician
fail
establish
correct
diagnosi
era
pressur
cost
effect
medic
care
diagnosi
case
requir
treatment
difficult
persuad
patient
doctor
perform
followup
investig
therefor
travel
symptom
acut
viral
fever
malaria
exclud
may
come
back
recov
anoth
reason
underestim
df
among
european
travel
centr
use
standardis
diagnost
procedur
febril
patient
addit
df
current
report
european
public
health
system
therefor
voluntarili
report
case
europ
still
repres
tip
iceberg
great
concern
possibl
dengu
outbreak
previous
denguefre
countri
via
import
case
spain
consid
noninfect
area
sever
survey
base
nonspecif
haemmaglutin
inhibit
assay
shown
seropreval
flavivirus
includ
dengu
viru
anoth
major
concern
potenti
area
dengu
transmiss
due
spread
vector
notabl
sizabl
part
unit
state
europ
thu
introduct
df
return
travel
afflict
diseas
pose
real
threat
public
health
system
western
world
one
largest
df
epidem
known
histori
involv
approxim
one
million
case
death
occur
greec
time
vector
later
erad
aegypti
context
recent
introduct
albopictu
europ
notabl
itali
albania
may
serv
warn
thing
come
infer
travel
potenti
acquir
spread
dengu
viru
infect
dengu
infect
consid
febril
patient
return
endem
area
without
typic
symptom
dengu
rule
symptom
begin
week
patient
left
endem
area
fever
last
week
import
dengu
nonimmun
travel
usual
take
favour
cours
global
expans
dengu
viru
increas
intern
travel
intensifi
possibl
sequenti
infect
risk
develop
dhf
dss
nevertheless
dhf
dss
rare
travel
histori
dengu
advis
protect
well
mosquito
travel
endem
area
df
also
emerg
problem
troop
deploy
dengueendem
tropic
countri
learn
point
travel
potenti
acquir
spread
dengu
viral
infect
dengu
infect
consid
febril
patient
return
endem
area
increas
intern
travel
intensifi
possibl
dhfdss
rare
travel
dengu
infect
emerg
problem
troop
deploy
endem
countri
